NATuRAL PRODuCT RESEARCH
5
a subfraction with compound (3) as its major constituent. Subsequent purification of this
subfraction by preparative TLC in 20 × 10-cm plates using hexane:ethyl acetate (9.5:0.5)
yielded compound (3) (250 mg). Compound (4) was precipitated as a white powder from Hfr
002, which was further purified by recrystallisation in hot chloroform (40 mg). Compound
(1) was obtained as a crude oily mixture from Hfr 003, further purified by column chroma-
tography in hexane:ethyl acetate (in gradient) and by preparative TLC in 20 × 10-cm plates
using hexane:ethyl acetate (9.5:0.5) (150 mg). Compound (5) was isolated from Hfr 004 by
repeated column chromatography using hexane:chloroform (20 mg). Compound (2) was iso-
lated from Hfr 005 as a white solid by repeated column chromatography using hexane:ethyl
acetate and hexane:chloroform (90 mg).
Chloroform extract (14 g) was fractionated by silica gel column chromatography
(5.5 × 90 cm) using 100% hexane, followed by increasing polarities of hexane-CHCl3, CHCl3-
MeOH and 100% MeOH. These fractions were pooled to six final fractions (Cfr 001 to 006)
based on their TLC profiles. Cfr 001 appeared as a waxy material and GC–MS confirmed it as a
mixture of hydrocarbons with major components as octadecane, hexadecane and eicosane.
Cfr 002 on repeated column chromatography and purification by preparative TLC resulted
in a white waxy compound (10, 22 mg). Cfr 003 on repeated column chromatography and
recrystallisation yielded a white solid (7, 31 mg). Compound (8, 18 mg) was isolated as a
white solid from Cfr 004 by repeated column chromatography and recrystallisation. Cfr 005
on column chromatography and recrystallisation yielded a yellow-coloured solid (6, 15 mg).
Cfr 006 on repeated column chromatography and preparative TLC yielded a fluorescent
compound (9, 10 mg). The purity of all isolates was confirmed by HPTLC and melting point
1
measurements. Compounds 1 to 10 were identified by H, 13C NMR, 2D NMR and mass
spectral analyses (Figure 1, Figure S1).
3.4. Lupan-20-ol-3(β)-yl hexadecanoate (1)
White waxy solid; m.p. 72 °C; αD25: + 10.098 (c = 0.1, CHCl3); IR λmax cm−1: 3513, 2920, 2849,
1729, 1713, 1466, 1379, 1264, 1245, 1224, 1182, 1102; 1H NMR (CDCl3, 400 MHz): δ = 0.99, 1.68
(2H, m, H-1), 1.28, 1.60 (2H, m, H-2), 4.48 (1H, dd, J = 6, 10 Hz, H-3), 0.79 (1H, t, J = 8.8 Hz, H-5),
1.49, 1.39 (2H, m, H-6), 1.40, 1.48 (2H, m, H-7), 1.28 (1H, m, H-9), 1.28, 1.49 (2H, m, H-11), 1.12,
1.79 (2H, m, H-12), 1.71 (1H, m, H-13), 1.32, 1.62 (2H, m, H-15), 1.49, 1.35 (2H, m, H-16), 1.33
(1H, m, H-18), 1.80 (1H, m, H-19), 1.62, 1.86 (2H, m, H-21), 1.12, 1.30 (2H, m, H-22), 0.84 (3H,
s, H-23), 0.84 (3H, s, H-24), 0.86 (3H, s, H-25), 1.06 (3H, s, H-26), 0.95 (3H, s, H-27), 0.81 (3H, s,
H-28), 1.12 (3H, s, H-29), 1.22 (3H, s, H-30), 2.29 (2H, t J = 7.6 Hz, H-2′), 1.60 (2H, m, H-3′), 1.25
(2H, br, s, H-4′-13′), 1.25 (2H, m, H-14′), 1.28 (2H, m, H-15′), 0.88 (3H, t, J = 6.4 Hz, H-16′); 13
C
NMR (CDCl3, 100 MHz): δ = 38.4 (CH2, C-1), 23.7 (CH2, C-2), 80.6 (CH, C-3), 37.8 (C, C-4), 55.3
(CH, C-5), 18.2 (CH2, C-6), 34.5 (CH2, C-7), 41.4 (C, C-8), 50.2 (CH, C-9), 37.0 (C, C-10), 21.4 (CH2,
C-11), 27.6 (CH2, C-12), 37.5 (CH, C-13), 43.5 (C, C-14), 28.7 (CH2, C-15), 35.6 (CH2, C-16), 44.6
(C, C-17), 48.3 (CH, C-18), 50.0 (CH, C-19), 73.5 (C, C-20), 29.0 (CH2, C-21), 40.2 (CH2, C-22),
28.0 (CH3, C-23), 16.6 (CH3, C-24), 16.2 (CH3, C-25), 16.2 (CH3, C-26), 14.8 (CH3, C-27), 19.2 (CH3,
C-28), 24.8 (CH3, C-29), 31.6 (CH3, C-30), 173.7 (C, C-1′), 34.9 (CH2, C-2′), 25.2 (CH2, C-3′), 29.2
(CH2, C-4′), 29.3 (CH2, C-5′), 29.5 (CH2, C-6′), 29.6 (CH2, C-7′-12′), 29.4 (CH2, C13′), 31.9 (CH2,
C-14′), 22.7 (CH2, C-15′), 14.1 (CH3, C-16′); HMBC correlations: H-1/C-3, C-12, C-25, H-2/C-4′,
C-3,C-1, H-3/C-1′, C-23, C-24, H-5/C-27, H-7/C-5, C-27, H-9/C-26, C-29, H-11/C-9, H-12/C-26,
H-18/C-19, C-28, H19/C-20,C-21, C-28, H-21/ C-20, H-22/C-17,C-20, C-28, H-23/C-3, C-4, C-5,